HiGenoMB® Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the pioneers in Indian BioSciences manufacturing segment adds another feather in the cap with their newly CE/IVD approved Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262).
Molecular Diagnostics based on real-time PCR is increasingly becoming the gold standard post COVID-19. Hi-PCR® COVID-FLU Multiplex Probe PCR Kit, is a multiplex PCR kit that can differentiate between COVID-19 and Flu using a single tube reaction. It is recommended for sensitive and specific detection of SARS-CoV-2 and Influenza virus in clinical samples. Targets include RdRp gene of SARS-CoV-2 virus, Influenza A virus (Swine flu 2009 H1N1 virus, seasonal H3N2 & seasonal H1N1), Influenza B virus and Internal control (IC).
Covid-19 pandemic has impacted millions of lives globally. The symptoms are similar to those of influenza, both being contagious respiratory illness. As the public's concern of contracting Covid-19 continued to rise, flu symptoms were frequently mistaken for those of Covid-19. Performing separate tests for detection of Covid-19 and Influenza can be time consuming, costly & a cumbersome affair. HiMedia’s MBPCR262 being a multiplex kit eliminates the need for separate tests thereby significantly reducing the time & resources.
Dr. Kavita Khadke, Director of HiMedia’s Molecular Biology Division (HiGenoMB®) says ‘’An early diagnostic tool that would help to differentiate between Flu and Covid-19 was the need of the hour. Time is of essence; this kit can give results in a short span, enabling rapid and appropriate detection that could help in early diagnosis & treatment.
Please visit their website www.himedialabs.com for more details about HiGenoMB® products related COVID Molecular testing.
This press release is published by VOH team.*
Mankind Pharma acquires majority stake in Upakarma Ayurveda
Ahmedabad doctors save Mumbai civic official’s life
BEAT-O RAISES $33 MILLION
HCG Cancer Hospital Bengaluru sets a new benchmark for Personalized cancer care
WOMEN’S WELLBEING FINDS NEW CUSTODIAN
ANOTHER WIN FOR THE DR. DANGS LAB TEAM
TOUCHLESS, SEAMLESS, MATCHLESS: Apollo Hospitals gives Gujarat its first digital
Dr. Dangs Lab honoured with Best Standalone Pathology Lab Award
Liver Transplant Training Gets Boost with New Book Launch
GENOMIC GIANT GOES GLOBAL
Dr. Arvind Sharma in the panel of board of directors of World Stroke Organizatio
Can India's First Connected Hospital Bed Platform Solve Healthcare's Jigsaw?
B Capital Helps Mojocare Raise $20.6 MN in Series A Round
From Climbing Stairs to Climbing EverestView All